Hexoskin’s Post

JOGO Health Announces Collaboration With Mayo Clinic to Study Tremors Using AI Powered Digital Therapeutics: 📲The partnership combines both organizations' expertise in medical analysis and device development, focusing on Parkinson's tremors, functional tremors (FT), and essential tremors (ET) 📲 The study aims to pressure test the effectiveness of AI-driven digital therapeutics in treating tremors that significantly impact the quality of life for individuals with Parkinson's, FT, and ET. 📲 Particular focus will be given to FT where current treatments are limited, often requiring patients to take substantial time off work or school 📲 JOGO Health and Mayo Clinic aspire to expand the range of viable treatment options, making specialized therapy more accessible and less disruptive to patients' daily lives 📲 JOGO Health's proprietary non-invasive digital therapeutic device, JOGO-Gx, integrates Al and wearable technology, having shown early success in treating Parkinson's Disease (Mayo Clinic have a financial interest in the tech) 📲 The upcoming study, planned start in September 2024, will run for one year, assessing the efficacy of this pioneering approach and guide further device development 📲 JOGO is a Digital Therapeutics company that uses wearable sensors and an AI-driven app to treat chronic pain, Parkinson's tremors and other movement disorders associated with neurological conditions via telemedicine 👇Link to relevant articles below in comments #digitalhealth #ai #dtx

Advanced Digital Biomarkers: Shaping the Future of Clinical Research In the evolving landscape of clinical research, advanced digital biomarkers are transformative tools revolutionizing disease understanding, diagnosis, and treatment. Derived from digital health technologies like wearables and mobile apps, these biomarkers enable continuous, real-time monitoring of physiological and behavioral data. The Power of Digital Biomarkers: Digital biomarkers offer a non-invasive, cost-effective way to gather comprehensive health data outside traditional clinical settings. This allows for the collection of longitudinal data, providing a dynamic and holistic view of a patient's health. For example, continuous glucose monitoring systems track blood glucose levels in diabetic patients in real-time, facilitating personalized diabetes management. Wearable devices monitor heart rate, sleep patterns, and physical activity, offering valuable insights into overall well-being. Recent Breakthroughs: Advancements in artificial intelligence (AI) and machine learning (ML) have enhanced the potential of digital biomarkers. AI-driven platforms analyze complex data sets to detect subtle health changes, enabling early diagnosis and intervention. For instance, AI models monitor cognitive decline in Alzheimer's patients using smartphone microphones or track Parkinson's disease progression through nocturnal breathing patterns. Transforming Clinical Trials: Integrating digital biomarkers into clinical trials streamlines the drug development process. Remote monitoring and decentralized trial designs reduce participant burden and increase data collection efficiency. This accelerates clinical research and enhances trial outcome accuracy and reliability. Digital endpoints from wearable devices provide continuous data on treatment response, offering a nuanced understanding of therapeutic efficacy. Overcoming Challenges: Despite their potential, adopting digital biomarkers in clinical research faces challenges like data privacy, standardization, and regulatory approval. Collaborative efforts among industry stakeholders, regulatory bodies, and academic institutions are crucial for developing robust frameworks for validating and implementing digital biomarkers. The Future of Precision Medicine: Integrating digital biomarkers with other data sources, such as genomics and proteomics, will pave the way for precision medicine. This multimodal approach will enable deeper insights into disease mechanisms and patient-specific treatment strategies, improving patient outcomes and advancing clinical research. In conclusion, advanced digital biomarkers are set to play a pivotal role in shaping the future of clinical research. By harnessing digital health technologies, we can unlock new possibilities for disease diagnosis, monitoring, and treatment, driving forward the vision of personalized and precision medicine. #ClinicalResearch

DUE TODAY! Applications are due today, Feb 21 by 11:59pm PT for the National Alzheimer's Coordinating Center and Gates Ventures’ Digital Biomarker Pilot Program that supports leveraging digital tools to validate biomarkers in #Alzheimers disease research. Up to three proposals will be funded, at $250k-$1M in direct costs each.  https://lnkd.in/gKxSTTqT   The Alzheimer’s Disease and Related Dementias Digital Biomarker Pilot Program is focused on advancing Alzheimer's Disease and related dementias research and discovery through digital innovation. Projects should leverage technology to capture richer and more objective data and advance the development and validation of digital biomarkers. Example tools include wearable devices, sensors, apps, software, large language modals, AI, and more.        The awards are open to anyone. All applicants must have at least two Alzheimer's Disease Research Center (ADRC) partners.     As part of the review process, top applicants will compete in a pitch competition in May 2024! Applicants whose proposals meet a minimum score threshold will pitch their pilot proposals to the review committee. Learn more about the review process and apply today: https://lnkd.in/gKxSTTqT          Key Dates        📅 February 21, 2024 by 11:59pm PT: Deadline for applications       📅 Spring 2024: Awardees are selected    

In the ever-evolving landscape of healthcare, the intersection of artificial intelligence (AI), cutting-edge technology, and patient-centric approaches is transforming cancer care and treatment. As we stride into a new era of medical innovation, these powerful tools are not just enhancing diagnostics and treatment efficacy, but also fundamentally reshaping the patient experience. AI algorithms are now capable of analyzing vast amounts of medical data, from genetic information to imaging scans, with unprecedented speed and accuracy. This computational prowess is enabling earlier cancer detection, more precise diagnoses, and personalized treatment plans tailored to each patient's unique genetic makeup and circumstances. Simultaneously, technological advancements are making cancer treatments more targeted and less invasive. From robotic surgery to proton beam therapy, these innovations are minimizing side effects and improving outcomes. Wearable devices and mobile apps are empowering patients to actively participate in their care, providing real-time monitoring and direct communication channels with healthcare providers. However, the true revolution lies in how these technological marvels are being harnessed to create a more patient-centric approach to cancer care. By placing the patient at the heart of the treatment journey, we're seeing a shift from a one-size-fits-all model to a nuanced, individualized approach that considers not just the medical aspects of care, but also the emotional, social, and practical needs of each patient. This holistic strategy recognizes that effective cancer care extends beyond the hospital walls. It encompasses support systems, quality of life considerations, and empowering patients with the knowledge and tools to make informed decisions about their treatment. As we continue to push the boundaries of what's possible in cancer care, the integration of AI, technology, and patient-centricity promises a future where cancer treatment is not just more effective, but also more humane, personalized, and empowering for those facing this challenging journey. ##AI #Technology #PatientCentricCare #CancerTreatment #HealthcareInnovation #PersonalizedMedicine

As we move into 2025, the healthcare sector is undergoing transformative changes driven by groundbreaking innovations in technology, personalized medicine, and patient care. From AI-powered diagnostics to wearable health devices and gene editing, the medical landscape is evolving faster than ever. Here’s a look at some of the most promising products and brands set to shape the future of healthcare: 🔍 AI & Diagnostics AI-powered diagnostic tools are making waves, with companies like Zebra Medical Vision and Google Health leading the charge. These technologies are enhancing diagnostic accuracy, predicting diseases early, and helping physicians make better-informed decisions. 💻 Telemedicine & Virtual Health Telemedicine platforms such as Teladoc Health and Amwell are revolutionizing healthcare delivery. With the rise of remote care, telehealth is improving access to medical services, particularly for rural or underserved populations. Meanwhile, remote patient monitoring devices are helping doctors track vital signs in real time. 🧬 Genomics & Personalized Medicine With the advancements in CRISPR technology, companies like CRISPR Therapeutics and Illumina are opening new frontiers in gene editing and sequencing, offering hope for treating genetic disorders, cancers, and other complex diseases with precision therapies tailored to individual genetic profiles. 🤖 Robotics in Surgery Robotic-assisted surgeries, led by Intuitive Surgical and Medtronic, are improving surgical precision, reducing recovery times, and minimizing the risks associated with traditional surgery. These innovations are advancing the future of minimally invasive procedures. 💉 Immunotherapies & Biotechnology In oncology, immunotherapies like Gilead Sciences’ CAR-T cell treatments and Bristol-Myers Squibb’s immuno-oncology breakthroughs are changing the way cancers are treated, offering more targeted therapies with fewer side effects. 🔬 Nanotechnology in Medicine Nanomedicine is poised to revolutionize drug delivery systems. Companies such as Nanobiotix are developing targeted therapies that use nanoparticles to deliver treatments directly to cancer cells, improving effectiveness and minimizing damage to healthy tissues. 📱 Health & Wellness Apps With a surge in interest around mental health, platforms like Headspace are offering digital therapy and mindfulness solutions, while MyFitnessPal continues to be a go-to for fitness and nutrition tracking. In 2025, these brands and products are not just pushing boundaries—they’re changing the way we think about healthcare. The future of medicine is personalized, digital, and driven by technology, paving the way for improved outcomes, more efficient treatments, and a healthier world. #HealthTech #Innovation #MedicalDevices #AIinHealthcare #Telemedicine #Wearables #Genomics #PersonalizedMedicine #FutureOfHealthcare #DigitalHealth #Globaltrade #Medicaltrade

🔬🚀 Exciting Updates in Biotech & Precision Medicine: 🧬 Genomic Advancements: The integration of AI and genomics is revolutionizing personalized medicine. Cutting-edge algorithms are deciphering complex genetic data, allowing for tailored treatments based on individual genetic profiles. 🔍 Biomarker Breakthroughs: Novel biomarkers are being discovered, offering deeper insights into disease progression and treatment responses. From liquid biopsies to tissue-based assays, biomarker testing is paving the way for early detection and targeted therapies. 💉 Immunotherapy Innovations: Immunoassays are at the forefront of cancer treatment, harnessing the power of the immune system to combat tumors. Breakthroughs in CAR-T cell therapy and checkpoint inhibitors are transforming the landscape of oncology, offering hope to patients with previously untreatable cancers. 🧠 Neurological Insights: Advances in neurology are unlocking mysteries of the brain, leading to innovative therapies for neurodegenerative diseases like Alzheimer's and Parkinson's. From neuroimaging techniques to neural interfaces, precision medicine is offering new hope for patients with neurological disorders. ⚙️ Precision Health Technologies: Cutting-edge technologies and equipment are enabling precision health initiatives worldwide. From wearable devices tracking vital signs to portable genetic sequencers, these innovations are empowering individuals to take control of their health like never before. Let's continue pushing the boundaries of science and medicine to create a healthier, more personalized future for all! #Biotech #PrecisionMedicine #Innovation #HealthTech 🌟🔬

𝐀𝐈 𝐚𝐧𝐝 𝐗𝐑-𝐏𝐨𝐰𝐞𝐫𝐞𝐝 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬: 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐀𝐥𝐳𝐡𝐞𝐢𝐦𝐞𝐫'𝐬 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐂𝐚𝐫𝐞 𝐟𝐨𝐫 𝐚 𝐍𝐞𝐰 𝐄𝐫𝐚 Alzheimer's Disease (AD) is becoming a pressing global challenge as populations age, and traditional approaches to diagnosis and treatment often fall short in early detection and personalized care. Enter Digital Therapeutics (DTx) powered by Artificial Intelligence (AI) and Extended Reality (XR), which are transforming the landscape of AD care. These advanced technologies offer non-invasive, adaptive, and patient-centered solutions by continuously monitoring cognitive and physiological data through wearable devices and analyzing digital behavior. AI-driven systems provide personalized interventions in real-time, while XR creates immersive therapeutic environments that engage patients in cognitive exercises and social interactions, enhancing their treatment experience. This integration of AI and XR allows for continuous monitoring, proactive care, and dynamically tailored therapies, shifting AD care from reactive to predictive. As these innovations advance, they promise to enhance the quality of life for both patients and caregivers, moving the field of AD care into a new era of personalized, digital-driven treatment. Video Link: https://lnkd.in/eRxnnxgY Join us for an engaging and insightful webinar that will explore the latest advancements and strategies in developing, patenting, and commercializing AI and XR-powered Digital Therapeutics (DTx). The focus will be on providing actionable insights into innovation frameworks, patent analysis, and best practices for aligning with regulatory frameworks such as the FDA AI/ML-Enabled Software as a Medical Device (SaMD) lifecycle. Attendees will gain insights into frameworks for developing cutting-edge DTx, intellectual property (IP) strategies, and the regulatory pathways essential for successfully bringing AI-powered products to market. The session will also highlight Generative AI (LLM) applications in DTx and explore the FDA’s Software as a Medical Device (SaMD) lifecycle framework to help participants align their innovations with evolving regulatory requirements. Agenda AI & XR Powered DTx Innovation Guide DTx Patents Analysis for AI & XR Powered Innovation Insights Patent Development for GenAI (LLM) Powered DTx AI Powered DTx Innovation Commercialization: FDA AI/ML-Enabled SaMD Lifecycle Management Framework Date and Time November 7, 2024 (Thursday) 12:00 PM – 1:00 PM ET Register Here: https://lnkd.in/eWxNHkjX #AI #XR #DigitalTherapeutics #DTx #𝐀𝐥𝐳𝐡𝐞𝐢𝐦𝐞𝐫'𝐬 #DigitalHealth #Innovation #Commercialization #SaMD #FDA #Patent #LLM

Digital twins, virtual replicas of physical entities, are gaining traction in healthcare 🩺👩⚕️ The global market for digital twins in healthcare is projected to reach $21.1 billion by 2028, up from $1.6 billion in 2023. At Johns Hopkins University, researchers are developing digital twins of human hearts to help treat patients with severe arrhythmias. These AI-powered 3D models enable precise predictions and treatment planning. But it's not just about hearts—Columbia University and the National Cancer Institute are also creating digital twins for pregnancy and cancer treatment. Could this technology revolutionize personalized medicine and save countless lives? 🩺🧠 Discover more about this groundbreaking innovation 👇

Transforming Cancer Care: How AI is Revolutionizing Early Detection! Regular check-ups are more than routine visits—they are a proactive approach to safeguarding your health. Early detection of conditions like cancer significantly improves treatment outcomes. Regular check-ups and health screenings remain our frontline defense, but Artificial Intelligence (AI) is emerging as a game-changer in this battle. 🌟 Why Early Detection Matters: ✳️ Early Detection Saves Lives: Routine screenings can detect issues before symptoms appear, giving you a better chance at effective treatment. ✳️ Comprehensive Health Monitoring: Doctors can identify risk factors and provide guidance to prevent health complications. ✳️ Longer, Healthier Life: By staying on top of your health, you’re investing in your future well-being. 🌟 How AI Enhances Early Detection AI-driven tools are rapidly advancing our ability to detect cancer early: ✳️ Precision Diagnostics: AI enhances imaging analysis, enabling more accurate detection of anomalies in mammograms, CT scans, and MRIs. ✳️ Predictive Models: AI algorithms analyze patient data to identify risk factors and provide tailored screening schedules. ✳️ Streamlined Workflows: AI-powered platforms assist oncologists by flagging high-risk cases, allowing us to focus where it matters most. ✳️ Remote Monitoring: Wearable technology and AI-powered apps help track health trends, providing actionable insights between appointments. 🌟A Collaborative Future The integration of AI doesn’t replace human expertise but amplifies it, allowing oncologists to deliver more precise, timely, and personalized care. As we embrace AI in oncology, we move closer to a future where routine check-ups paired with advanced technology lead to earlier diagnoses and better outcomes for our patients. Dr. Amit Kumar Jain - Best Leading Oncologist and Hematologist in Bangalore. MBBS, MD - General Medicine DNB - Medical Oncology For Appointment: 📞 +91 91486 90492 #AIinOncology #EarlyDetection #CancerAwareness #HealthTech #InnovationInHealthcare #EarlyDetectionSavesLives #DrAmitKumarJain #DrAmitJainOnco

Thoughts on this? >> Paige Unveils AI Co-Pilot for Pathology & Oncology, Paige Alba >> Comment below! >>> socialpharma.net #digitalhealth #industry40 #healthcare #AI #IoT #healthtech #mhealth #wearables